Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...

In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

The data shows that the average rate of adolescents starting treatment with the Novo Nordisk (NYSE: NVO) drug increased by 50 ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...